Risperidone liquid in psychotic disorders - Efficacy and attitudes

Psychiatria Danubina

Volumn 17, Issue 3-4, 2005, Pages 191-196

  Jašović Gašić, Miroslava ^a   Marić, Nadja ^a   Damjanović, Aleksandar ^a  

^a Clinical Centre of Serbia   (Serbia)

Author keywords

Attitudes psychotic disorders; Risperidone liquid efficacy

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; RISPERIDONE;

ADULT; AGED; AKATHISIA; AMENORRHEA; ARTICLE; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENTAL HEALTH; MULTICENTER STUDY; OPEN STUDY; PARANOIA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; QUESTIONNAIRE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOTYPAL PERSONALITY DISORDER; SEDATION; SOMNOLENCE; TABLET FORMULATION; TREATMENT OUTCOME; WEIGHT GAIN; YUGOSLAVIA;

EID: 28944453338     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Abraham TM: Risperidone liquid treatment of acute mania. Can J Psychiatry 2003;48: 425.
2. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D et al: Attitudes toward antipsychotic medication: the impact of clinical variables and relationship with health professionals. Arch Gen Psychiatry 2005;62: 717-24.
3. Gardner DM, Baldessarini RJ, Waraich P: Modern antipsychotic drugs: a critical overview. CMAJ 2005;172(13): 1703-1711.
4. Jašović-Gašić M&Marić N: Risperidon vs. Other Antipsychotics in Schizophrenia: The Assesment of Patients' Attitudes. Psychiatria Danubina 2004; 16(3):127-31.
5. Love RC, Conley RR, Kelly DL&Bartko JJ: A dose-outcome analysis of risperidone. J Clin Psyhitry 1999;60: 771-5.
6. Luchins DJ, Klass D, Hanrahan P, Malan R& Harris J: Alteration in the recommended dosing schedule for risperidone. Am J Psychiatry 1998;155:365-6.
7. Patel MX, Nikolaou V& David AS: Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol Med 2003;33: 83-9.
8. Williams R: Optimal dosing with risperidone: updated recommendations. J Clin Psychiatry 2001;62: 282-9.
9. Yoshimura R, Nakamura J, Shinkai K, Goto M, Yamada Y, Kaji K, Kakihara S et al: An open study of risperidone in the acute phase of schizophrenia. Hum Psychopharmacol 2005;20: 243-8.